DE69816241D1 - Aktivierte peptide und konjugate - Google Patents

Aktivierte peptide und konjugate

Info

Publication number
DE69816241D1
DE69816241D1 DE69816241T DE69816241T DE69816241D1 DE 69816241 D1 DE69816241 D1 DE 69816241D1 DE 69816241 T DE69816241 T DE 69816241T DE 69816241 T DE69816241 T DE 69816241T DE 69816241 D1 DE69816241 D1 DE 69816241D1
Authority
DE
Germany
Prior art keywords
conjugates
activated peptides
peptides
activated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69816241T
Other languages
English (en)
Other versions
DE69816241T2 (de
Inventor
E Annunziato
S Palumbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syva Co
Original Assignee
Syva Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syva Co filed Critical Syva Co
Publication of DE69816241D1 publication Critical patent/DE69816241D1/de
Application granted granted Critical
Publication of DE69816241T2 publication Critical patent/DE69816241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
DE69816241T 1997-04-07 1998-04-02 Aktivierte peptide und konjugate Expired - Lifetime DE69816241T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/833,546 US5977299A (en) 1997-04-07 1997-04-07 Activated peptides and conjugates
US833546 1997-04-07
PCT/US1998/006545 WO1998045318A1 (en) 1997-04-07 1998-04-02 Activated peptides and conjugates

Publications (2)

Publication Number Publication Date
DE69816241D1 true DE69816241D1 (de) 2003-08-14
DE69816241T2 DE69816241T2 (de) 2004-04-15

Family

ID=25264718

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69816241T Expired - Lifetime DE69816241T2 (de) 1997-04-07 1998-04-02 Aktivierte peptide und konjugate
DE69833061T Expired - Lifetime DE69833061T2 (de) 1997-04-07 1998-04-02 Aktivierte Peptide und deren Konjugate

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69833061T Expired - Lifetime DE69833061T2 (de) 1997-04-07 1998-04-02 Aktivierte Peptide und deren Konjugate

Country Status (6)

Country Link
US (2) US5977299A (de)
EP (2) EP1336616B1 (de)
JP (1) JP4120846B2 (de)
DE (2) DE69816241T2 (de)
ES (2) ES2254820T3 (de)
WO (1) WO1998045318A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062945A2 (en) * 1998-06-05 1999-12-09 Peptide Solutions, Inc. Peptide antigens for detection of hiv, hcv and other microbial infections
US6210908B1 (en) * 1998-11-11 2001-04-03 Dade Behring Marburg Gmbh Activated peptides and conjugates
AU2001235365A1 (en) * 2000-02-23 2001-09-03 Besst-Test Aps Method for correlating blood coagulation activity with markers in body fluids, e.g. urine
US6913890B2 (en) * 2002-12-18 2005-07-05 Palo Alto Research Center Incorporated Process for preparing albumin protein conjugated oligonucleotide probes
WO2013101626A1 (en) 2011-12-30 2013-07-04 Ticona Llc Molded polymer articles for use in low temperatures having a low rigidity factor
EP2647666A1 (de) 2012-04-05 2013-10-09 Ticona GmbH Tribologisch modifiziertes Polyoxymethylen
US9328229B2 (en) 2012-05-09 2016-05-03 Ticona Llc Polymer composition and articles for use in low temperature environments that are wear resistant
WO2014015111A1 (en) 2012-07-18 2014-01-23 Ticona Llc Wear resistant thermoplastic copolyester elastomer
US10196577B2 (en) 2015-09-30 2019-02-05 Celanese Sales Germany Gmbh Low friction squeak free assembly

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066782A (en) * 1986-01-22 1991-11-19 Institut Pasteur Retrovirus capable of causing AIDS, means and method for detecting it in vitro
US5574132A (en) * 1991-04-05 1996-11-12 Biochem Immunosystems Inc. Peptides and mixtures thereof for detecting antibodies to hepatitis C virus (HCV)
NZ243636A (en) * 1991-07-29 1993-06-25 Iaf Biochem Int Immunoassay and kit for simultaneously detecting antibodies to hiv-1, hiv-2, htlv-1 and htlv-11
WO1993009252A1 (en) * 1991-11-04 1993-05-13 Baxter Diagnostics Inc. Synthetic peptides corresponding to portions of hiv-2 virus and methods of using in an improved assay
US5294536A (en) * 1992-04-23 1994-03-15 Pb Diagnostic Systems, Inc. Conjugates
DE4405810A1 (de) * 1994-02-23 1995-08-24 Behringwerke Ag Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung

Also Published As

Publication number Publication date
EP0920443A1 (de) 1999-06-09
EP1336616A1 (de) 2003-08-20
US20030004320A1 (en) 2003-01-02
EP0920443B1 (de) 2003-07-09
US5977299A (en) 1999-11-02
US6593453B2 (en) 2003-07-15
JP2000515169A (ja) 2000-11-14
DE69833061T2 (de) 2006-08-31
ES2254820T3 (es) 2006-06-16
JP4120846B2 (ja) 2008-07-16
ES2202829T3 (es) 2004-04-01
DE69816241T2 (de) 2004-04-15
DE69833061D1 (de) 2006-03-30
WO1998045318A1 (en) 1998-10-15
EP1336616B1 (de) 2006-01-04

Similar Documents

Publication Publication Date Title
BR9607317A (pt) Peptídios e composição farmacêutica
BR9607318A (pt) Peptidos e composição farmacêutica
DK1042359T3 (da) k-Opioidreceptorpeptider
DE69828330D1 (de) Aktiviertes Protein C Formulierungen
DE69526801D1 (de) Aerosolformulierungen mit peptiden und proteinen
DE69911579D1 (de) Antimikrobielle peptide
NO985680D0 (no) Peptidderivater
GB9806806D0 (en) Peptides and uses thereof
NO983849L (no) Peptidderivater
EE04001B1 (et) Peptiidne farmatseutiline kompositsioon
DE69816241D1 (de) Aktivierte peptide und konjugate
FI963334A (fi) Tyrosinaasista peräisin olevat eristetyt peptidit ja niiden käyttö
IL131707A0 (en) Acetylcholinesterase-derived peptides and uses thereof
DE69836500D1 (de) Antifungale und antibakterielle peptide
HK1046925A1 (zh) Mage-a12抗原肽及其用途
GB9918155D0 (en) Proteins and peptides
DE69427363D1 (de) Plättchenaggregationsinhibierende peptide
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
GB9714276D0 (en) Peptides and related compounds
KR960010685A (ko) 펩티드 및 그 용도
GB2336844B (en) Anti-hiv peptides and proteins
DE69638206D1 (de) Antineoplastische Peptide
EP0975610A4 (de) Tripeptide und tetrapeptide als pharmazeutische verbindungen
DK1017798T3 (da) Lunasinpeptider
NO20000976D0 (no) Peptider

Legal Events

Date Code Title Description
8364 No opposition during term of opposition